Please use this identifier to cite or link to this item:
https://doi.org/10.18632/oncotarget.6723
DC Field | Value | |
---|---|---|
dc.title | CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling | |
dc.contributor.author | Cui, H.-Y | |
dc.contributor.author | Wang, S.-J | |
dc.contributor.author | Miao, J.-Y | |
dc.contributor.author | Fu, Z.-G | |
dc.contributor.author | Feng, F | |
dc.contributor.author | Wu, J | |
dc.contributor.author | Yang, X.-M | |
dc.contributor.author | Chen, Z.-N | |
dc.contributor.author | Jiang, J.-L | |
dc.date.accessioned | 2020-10-27T05:30:02Z | |
dc.date.available | 2020-10-27T05:30:02Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Cui, H.-Y, Wang, S.-J, Miao, J.-Y, Fu, Z.-G, Feng, F, Wu, J, Yang, X.-M, Chen, Z.-N, Jiang, J.-L (2016). CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget 7 (5) : 5613-5629. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.6723 | |
dc.identifier.issn | 19492553 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/180863 | |
dc.description.abstract | The acquisition of inappropriate migratory feature is crucial for tumor metastasis. It has been suggested that CD147 and Annexin A2 are involved in regulating tumor cell movement, while the regulatory mechanisms are far from clear. In this study, we demonstrated that CD147 physically interacted with the N-terminal domain of Annexin A2 and decreased Annexin A2 phosphorylation on tyrosine 23. In vitro kinase assay showed that the I domain of CD147 was indispensable for CD147-mediated downregulation of Annexin A2 phosphorylation by Src. Furthermore, we determined that p-Annexin A2 promoted the expression of dedicator of cytokinesis 3 (DOCK3) and DOCK3 blocked β-catenin nuclear translocation, resulting in inhibition of β-catenin signaling. In addition, DOCK3 inhibited lamellipodium dynamics and tumor cell movement. Also, we found that β-catenin signaling increased WAVE2 expression. Therefore, DOCK3 was characterized as a negative regulator of WAVE2 expression via inhibiting β-catenin signaling. Our study provides the first evidence that CD147 promotes tumor cell movement and metastasis via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling axis. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | beta catenin | |
dc.subject | CD147 antigen | |
dc.subject | dedicator of cytokinesis 3 protein | |
dc.subject | guanine nucleotide exchange factor | |
dc.subject | lipocortin 2 | |
dc.subject | unclassified drug | |
dc.subject | WAVE2 protein | |
dc.subject | ANXA2 protein, human | |
dc.subject | beta catenin | |
dc.subject | BSG protein, human | |
dc.subject | CD147 antigen | |
dc.subject | CTNNB1 protein, human | |
dc.subject | DOCK3 protein, human | |
dc.subject | guanine nucleotide exchange factor | |
dc.subject | lipocortin 2 | |
dc.subject | messenger RNA | |
dc.subject | nerve protein | |
dc.subject | small interfering RNA | |
dc.subject | WASF2 protein, human | |
dc.subject | Wiskott Aldrich syndrome protein | |
dc.subject | A549 cell line | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | Article | |
dc.subject | cell migration | |
dc.subject | cell motility | |
dc.subject | cell nucleus | |
dc.subject | cellular distribution | |
dc.subject | controlled study | |
dc.subject | down regulation | |
dc.subject | hepatocellular carcinoma cell line | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | lamellipodium | |
dc.subject | liver cell carcinoma | |
dc.subject | male | |
dc.subject | metastasis | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | protein domain | |
dc.subject | protein phosphorylation | |
dc.subject | protein protein interaction | |
dc.subject | signal transduction | |
dc.subject | animal | |
dc.subject | antagonists and inhibitors | |
dc.subject | apoptosis | |
dc.subject | Bagg albino mouse | |
dc.subject | cell motion | |
dc.subject | cell proliferation | |
dc.subject | chemistry | |
dc.subject | drug screening | |
dc.subject | fluorescent antibody technique | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | liver tumor | |
dc.subject | metabolism | |
dc.subject | nude mouse | |
dc.subject | pathology | |
dc.subject | phosphorylation | |
dc.subject | real time polymerase chain reaction | |
dc.subject | reverse transcription polymerase chain reaction | |
dc.subject | secondary | |
dc.subject | surface plasmon resonance | |
dc.subject | tumor cell culture | |
dc.subject | Western blotting | |
dc.subject | Animals | |
dc.subject | Annexin A2 | |
dc.subject | Antigens, CD147 | |
dc.subject | Apoptosis | |
dc.subject | beta Catenin | |
dc.subject | Blotting, Western | |
dc.subject | Carcinoma, Hepatocellular | |
dc.subject | Cell Movement | |
dc.subject | Cell Proliferation | |
dc.subject | Fluorescent Antibody Technique | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | Guanine Nucleotide Exchange Factors | |
dc.subject | Humans | |
dc.subject | Liver Neoplasms | |
dc.subject | Male | |
dc.subject | Mice | |
dc.subject | Mice, Inbred BALB C | |
dc.subject | Mice, Nude | |
dc.subject | Nerve Tissue Proteins | |
dc.subject | Phosphorylation | |
dc.subject | Real-Time Polymerase Chain Reaction | |
dc.subject | Reverse Transcriptase Polymerase Chain Reaction | |
dc.subject | RNA, Messenger | |
dc.subject | RNA, Small Interfering | |
dc.subject | Signal Transduction | |
dc.subject | Surface Plasmon Resonance | |
dc.subject | Tumor Cells, Cultured | |
dc.subject | Wiskott-Aldrich Syndrome Protein Family | |
dc.subject | Xenograft Model Antitumor Assays | |
dc.type | Article | |
dc.contributor.department | PHYSICS | |
dc.description.doi | 10.18632/oncotarget.6723 | |
dc.description.sourcetitle | Oncotarget | |
dc.description.volume | 7 | |
dc.description.issue | 5 | |
dc.description.page | 5613-5629 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_18632_oncotarget_6723.pdf | 6.56 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License